Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands		6 Months Ended
		Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities:
Net income (loss)		$ (3,122)	$ 32,664
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation		7,804	9,485
Amortization of intangible assets		2,251	3,064
Reduction in carrying amount of right-of-use asset		4,894	5,891
Provision for credit losses		27	82
Share-based compensation		41,219	40,876
Deferred income taxes		(987)	(21)
Provision (Benefit) for excess and obsolete inventory	[1]	(271)	16,043
Non-cash interest expense		594	532
Other		(801)	(2,481)
Changes in operating assets and liabilities:
Accounts receivable, net		(28,083)	69,915
Inventories	[1]	411	(80,595)
Prepaid expenses and other assets		(9,969)	(7,850)
Accounts payable		1,177	(12,263)
Accrued compensation and benefits		16,995	(20,625)
Operating lease liabilities		(5,375)	(6,444)
Deferred revenue		17,421	48,272
Other current and long-term liabilities		(4,067)	13,320
Net cash provided by operating activities		40,118	109,865
Cash flows from investing activities:
Capital expenditures		(12,325)	(9,955)
Net cash used in investing activities		(12,325)	(9,955)
Cash flows from financing activities:
Net payments on revolving facility			(25,000)
Payments on debt obligations		(5,000)	(5,000)
Payments on debt financing costs		(695)
Repurchase of common stock			(49,855)
Payments for tax withholdings, net of proceeds from issuance of common stock		(8,300)	(33,387)
Net cash used in financing activities		(13,995)	(113,242)
Foreign currency effect on cash and cash equivalents		(175)	(91)
Net increase (decrease) in cash and cash equivalents		13,623	(13,423)
Cash and cash equivalents at beginning of period		156,699	234,826
Cash and cash equivalents at end of period		$ 170,322	$ 221,403

[1] The prior period amounts have been reclassified to conform to the current period presentation